{"schema_version":"secwatch.filing_event.v1","accession":"0001323885-25-000101","form_type":"8-K/A","ticker":"ATRC","cik":"0001323885","company_name":"AtriCure, Inc.","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.089503+00:00","generated_at":"2026-05-17T01:36:06.213594+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"AtriCure Q3 revenue $134.3M (+15.8% YoY); net loss narrows to $0.3M; raises FY2025 outlook","bullets":["Revenue $134.3M, +15.8% YoY (+15.1% constant currency); US $109.3M (+14.5%), intl $25.0M (+22.0%).","Net loss $0.3M vs $7.9M loss in Q3 2024; GAAP EPS loss $0.01 vs $0.17; adjusted EBITDA $17.8M (+$9.9M).","Generated $30.1M cash in Q3, $25.1M YTD; raised full-year 2025 financial outlook.","Key product drivers: AtriClip FLEX-Mini, EnCompass clamp, cryoSPHERE MAX probe for pain management.","Gross margin 75.5%, up 59 bps YoY on favorable product mix."],"urls":{"canonical":"https://secwatch.observer/filing/0001323885-25-000101","json":"https://secwatch.observer/filing/0001323885-25-000101.json","markdown":"https://secwatch.observer/filing/0001323885-25-000101.md","text":"https://secwatch.observer/filing/0001323885-25-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000101/0001323885-25-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000101/atrc-20251029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:36:06.213594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}